相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。152O A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours
V. Teneggi et al.
ANNALS OF ONCOLOGY (2017)
Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors
Zachary Steinhart et al.
NATURE MEDICINE (2017)
Wnt5a promotes Frizzled-4 signalosome assembly by stabilizing cysteine-rich domain dimerization
Zachary J. DeBruine et al.
GENES & DEVELOPMENT (2017)
Unsaturated fatty acyl recognition by Frizzled receptors mediates dimerization upon Wnt ligand binding
Aaron H. Nile et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation
Birdal Bilir et al.
CANCER RESEARCH (2016)
A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis
Liang Fang et al.
CANCER RESEARCH (2016)
Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer
Eun-Jin Yun et al.
CLINICAL CANCER RESEARCH (2016)
Abstract C45: Phase I study of WNT974, a first-in-class Porcupine inhibitor, in advanced solid tumors
Filip Janku et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function
Elaine E. Storm et al.
NATURE (2016)
Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis
S. H. Lee et al.
ONCOGENE (2016)
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
B. Madan et al.
ONCOGENE (2016)
The molecular and cellular origin of human prostate cancer
John R. Packer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Adenovirus vector carrying REICIDKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy
H. Kumon et al.
CANCER GENE THERAPY (2016)
SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms
Pilar Garcia-Tobilla et al.
GENE (2016)
Androgen deprivation modulates gene expression profile along prostate cancer progression
Marco Volante et al.
HUMAN PATHOLOGY (2016)
Expression and colocalization of β-catenin and Lymphoid enhancing factor-1 in prostate cancer progression
Tyler M. Bauman et al.
HUMAN PATHOLOGY (2016)
CKAP4 is a Dickkopf1 receptor and is involved in tumor progression
Hirokazu Kimura et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
SOX9 drives WNT pathway activation in prostate cancer
Fen Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment
Y. Sun et al.
ONCOGENE (2016)
β-Catenin-Independent Roles of Wnt/LRP6 Signaling
Sergio P. Acebron et al.
TRENDS IN CELL BIOLOGY (2016)
Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer
Chengfei Liu et al.
ONCOTARGET (2016)
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
Kamal Ahmed et al.
CANCERS (2016)
Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?
Melody Mazon et al.
CANCERS (2016)
Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer
Huai-Xiang Hao et al.
CANCERS (2016)
Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat Cancer
Toby Phesse et al.
CANCERS (2016)
Triptonide Effectively Inhibits Wnt/β-Catenin Signaling via C-terminal Transactivation Domain of β-catenin
Jessica Chinison et al.
SCIENTIFIC REPORTS (2016)
Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Jiun-Hung Geng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Androgen receptor and prostate cancer
Karen E. Livermore et al.
AIMS MOLECULAR SCIENCE (2016)
Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells
Monica Cojoc et al.
CANCER RESEARCH (2015)
Alternative Wnt Signaling Activates YAP/TAZ
Hyun Woo Park et al.
CELL (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway
Sebastien Martinez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
WNT5A Has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo
Stefanie Thiele et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen
Aurelie Mallinger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Targeting Wnts at the Source-New Mechanisms, New Biomarkers, New Drugs
Babita Madan et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Phuong N. Le et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Ror2 as a Therapeutic Target in Cancer
Zufan Debebe et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Concurrent Hepsin overexpression and adenomatous polyposis coli deletion causes invasive prostate carcinoma in mice
Kenneth C. Valkenburg et al.
PROSTATE (2015)
Estrogen Induces Androgen-Repressed SOX4 Expression to Promote Progression of Prostate Cancer Cells
Muyi Yang et al.
PROSTATE (2015)
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T. Miyamoto et al.
SCIENCE (2015)
CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer
Michael Bordonaro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively
Kensaku Shojima et al.
SCIENTIFIC REPORTS (2015)
Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
Wenqi Wang et al.
CELL REPORTS (2015)
Targeting Wnt Canonical Signaling by Recombinant sFRP1 Bound Luminescent Au-Nanocluster Embedded Nanoparticles in Cancer Theranostics
Archita Ghoshal et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Targeting Wnt Canonical Signaling by Recombinant sFRP1 Bound Luminescent Au-Nanocluster Embedded Nanoparticles in Cancer Theranostics
Archita Ghoshal et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study
Adriana C. Vidal et al.
CLINICAL CANCER RESEARCH (2015)
Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth
Nan Li et al.
GENES & DEVELOPMENT (2015)
Androgens and androgen receptor signaling in prostate tumorigenesis
Ye Zhou et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy
Hiromi Kumon et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients
Tilman D. Rachner et al.
BMC CANCER (2014)
Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction
G. T. Lee et al.
BRITISH JOURNAL OF CANCER (2014)
WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3
J. P. Dijksterhuis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
LEF1 and B9L Shield β-Catenin from Inactivation by Axin, Desensitizing Colorectal Cancer Cells to Tankyrase Inhibitors
Marc de la Roche et al.
CANCER RESEARCH (2014)
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
Luca Azzolin et al.
CELL (2014)
A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis
Taranjit S. Gujral et al.
CELL (2014)
Genes Upregulated in Prostate Cancer Reactive Stroma Promote Prostate Cancer Progression In Vivo
Olga Dakhova et al.
CLINICAL CANCER RESEARCH (2014)
Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Chengfei Liu et al.
CLINICAL CANCER RESEARCH (2014)
Extracellular modulators of Wnt signalling
Tomas Malinauskas et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)
Tankyrases: Structure, Function and Therapeutic Implications in Cancer
Teemu Haikarainen et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
Prabhakar Rajan et al.
EUROPEAN UROLOGY (2014)
Salinomycin Suppresses LRP6 Expression and Inhibits Both Wnt/β-catenin and mTORC1 Signaling in Breast and Prostate Cancer Cells
Wenyan Lu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Adaptive Dose-Finding Studies: A Review of Model-Guided Phase I Clinical Trials
Alexia Iasonos et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of 11C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil
Kazuhiro Kitajima et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Mitotic Wnt Signaling Promotes Protein Stabilization and Regulates Cell Size
Sergio P. Acebron et al.
MOLECULAR CELL (2014)
Crosstalk Between Nuclear MET and SOX9/β-Catenin Correlates with Castration-Resistant Prostate Cancer
Yingqiu Xie et al.
MOLECULAR ENDOCRINOLOGY (2014)
Can we safely target the WNT pathway?
Michael Kahn
NATURE REVIEWS DRUG DISCOVERY (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
The Role of Ryk and Ror Receptor Tyrosine Kinases in Wnt Signal Transduction
Jennifer Green et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
ROR1, an embryonic protein with an emerging role in cancer biology
Nicholas Borcherding et al.
PROTEIN & CELL (2014)
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
Joachim Weischenfeldt et al.
CANCER CELL (2013)
Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer
Kyle David Proffitt et al.
CANCER RESEARCH (2013)
ERG Is a Critical Regulator of Wnt/LEF1 Signaling in Prostate Cancer
Longtao Wu et al.
CANCER RESEARCH (2013)
Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
Himisha Beltran et al.
EUROPEAN UROLOGY (2013)
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer
Antoinette S. Perry et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Identification of NVP-TNKS656: The Use of Structure-Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor
Michael D. Shultz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Dishevelled-2 silencing reduces androgen-dependent prostate tumor cell proliferation and migration and expression of Wnt-3a and matrix metalloproteinases
Yinhui Yang et al.
MOLECULAR BIOLOGY REPORTS (2013)
Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer
Dali Zheng et al.
MOLECULAR CANCER RESEARCH (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
Xiaomo Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Inhibition of androgen receptor and β-catenin activity in prostate cancer
Eugine Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
Chun-Liang Chen et al.
PROSTATE (2013)
Secreted and Transmembrane Wnt Inhibitors and Activators
Cristina-Maria Cruciat et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Selective Small Molecule Targeting β-Catenin Function Discovered by In Vivo Chemical Genetic Screen
Jijun Hao et al.
CELL REPORTS (2013)
β-Catenin Is Required for Prostate Development and Cooperates with Pten Loss to Drive Invasive Carcinoma
Jeffrey C. Francis et al.
PLOS GENETICS (2013)
Clinical Significance of Wnt/ β-Catenin Signalling and Androgen Receptor Expression in Prostate Cancer
Soo Jin Jung et al.
WORLD JOURNAL OF MENS HEALTH (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
Wnt11 in 2011-the regulation and function of a non-canonical Wnt
P. Uysal-Onganer et al.
ACTA PHYSIOLOGICA (2012)
The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
Suping Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
The many roles of PTK7: A versatile regulator of cell-cell communication
Hanna Peradziryi et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Structure-Based Discovery of a Novel Inhibitor Targeting the β-Catenin/Tcf4 Interaction
Wang Tian et al.
BIOCHEMISTRY (2012)
Targeting the Wnt pathway in cancer: The emerging role of Dickkopf-3
Juergen Veeck et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
An Anti-Wnt5a Antibody Suppresses Metastasis of Gastric Cancer Cells In Vivo by Inhibiting Receptor-Mediated Endocytosis
Hideaki Hanaki et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Reexpression of Tumor Suppressor, sFRP1, Leads to Antitumor Synergy of Combined HDAC and Methyltransferase Inhibitors in Chemoresistant Cancers
Simon J. Cooper et al.
MOLECULAR CANCER THERAPEUTICS (2012)
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner
Huai-Xiang Hao et al.
NATURE (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Zheng Sun et al.
NATURE MEDICINE (2012)
The complex world of WNT receptor signalling
Christof Niehrs
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Wnt/β-catenin signalling in prostate cancer
Robert M. Kypta et al.
NATURE REVIEWS UROLOGY (2012)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Drivers and hotspots of extinction risk in marine mammals
Ana D. Davidson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural Basis of Wnt Recognition by Frizzled
Claudia Y. Janda et al.
SCIENCE (2012)
Frizzled and LRP5/6 Receptors for Wnt/β-Catenin Signaling
Bryan T. MacDonald et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer
Azharuddin Sajid Syed Khaja et al.
CANCER MEDICINE (2012)
TMPRSS2-ERG- specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
Jan C. Brase et al.
BMC CANCER (2011)
Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo
Cuihong Lin et al.
FEBS LETTERS (2011)
The role of secreted frizzled-related protein 2 expression in prostate cancer
Gillian O'Hurley et al.
HISTOPATHOLOGY (2011)
Expression Profile of WNT Molecules in Prostate Cancer and its Regulation by Aminobisphosphonates
Sylvia Thiele et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome
Azharuddin Sajid Syed Khaja et al.
PLOS ONE (2011)
Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer
Sayuri Takahashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway
Foster C. Gonsalves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Dickkopf-1 (DKK-1) Stimulated Prostate Cancer Growth and Metastasis and Inhibited Bone Formation in Osteoblastic Bone Metastases
Nanda K. Thudi et al.
PROSTATE (2011)
Association Analysis of Wnt Pathway Genes on Prostate-Specific Antigen Recurrence After Radical Prostatectomy
Shu-Pin Huang et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
Santosh Gupta et al.
CANCER RESEARCH (2010)
Current management of castrate-resistant prostate cancer
S. J. Hotte et al.
Current Oncology (2010)
The Hippo Pathway Regulates Wnt/β-Catenin Signaling
Xaralabos Varelas et al.
DEVELOPMENTAL CELL (2010)
The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition
David S. Yee et al.
MOLECULAR CANCER (2010)
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
Pinar Uysal-Onganer et al.
MOLECULAR CANCER (2010)
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase
H. Yamamoto et al.
ONCOGENE (2010)
International Union of Basic and Clinical Pharmacology. LXXX. The Class Frizzled Receptors
Gunnar Schulte
PHARMACOLOGICAL REVIEWS (2010)
Tumor-stroma co-evolution in prostate cancer progression and metastasis
Sajni Josson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Wnt signal transduction pathways
Yuko Komiya et al.
Organogenesis (2010)
Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes
Laura E. Pascal et al.
BMC CANCER (2009)
LEF1 in Androgen-Independent Prostate Cancer: Regulation of Androgen Receptor Expression, Prostate Cancer Growth, and Invasion
Yirong Li et al.
CANCER RESEARCH (2009)
WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
Isabelle Bisson et al.
CELL RESEARCH (2009)
Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
David Grandy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Baozhi Chen et al.
NATURE CHEMICAL BIOLOGY (2009)
NFAT proteins: emerging roles in cancer progression
Maria Mancini et al.
NATURE REVIEWS CANCER (2009)
Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10
Chikako Fukukawa et al.
CANCER SCIENCE (2008)
The Wnt-5a-Derived Hexapeptide Foxy-5 Inhibits Breast Cancer Metastasis In vivo by Targeting Cell Motility
Annette Safholm et al.
CLINICAL CANCER RESEARCH (2008)
Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease
Paola Bovolenta et al.
JOURNAL OF CELL SCIENCE (2008)
Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
X. Li et al.
ONCOGENE (2008)
Alternative Wnt Signaling Is Initiated by Distinct Receptors
Renee van Amerongen et al.
SCIENCE SIGNALING (2008)
Wnt signalling and its impact on development and cancer
Alexandra Klaus et al.
NATURE REVIEWS CANCER (2008)
Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone
Z. G. Li et al.
ONCOGENE (2008)
TMPRSS2-ERG fusion prostate cancer:: An early molecular event associated with invasion
Sven Perner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Wnts as ligands: processing, secretion and reception
A. J. Mikels et al.
ONCOGENE (2006)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer
Stephane Terry et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells
A Säfholm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Wnt and calcium signaling:: β-Catenin-independent pathways
AD Kohn et al.
CELL CALCIUM (2005)
Up-regulation of Wnt-1 and β-catenin production in patients with advanced metastatic prostate carcinoma -: Potential pathogenetic and prognostic implications
GP Chen et al.
CANCER (2004)
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
KH Emami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Analysis of Wnt gene expression in prostate cancer: Mutual enhibition by WNT11 and the androgen receptor
HN Zhu et al.
CANCER RESEARCH (2004)
The Wnt signaling pathway in development and disease
CY Logan et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
AP-1: A double-edged sword in tumorigenesis
R Eferl et al.
NATURE REVIEWS CANCER (2003)
A second canon:: Functions and mechanisms of β-catenin-independent wnt signaling
MT Veeman et al.
DEVELOPMENTAL CELL (2003)
Secreted antagonists of the Wnt signalling pathway
Y Kawano et al.
JOURNAL OF CELL SCIENCE (2003)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
分享论文
